Episode

Weight-Loss Drugs Are Gobbling Up Small Town Budgets

Podcast
The Journal.
Published
Jun 29, 2026
Duration seconds
1168
Processing state
not_requested
Canonical source
https://pdst.fm/e/traffic.megaphone.fm/WSJ1289536708.mp3
Audio
https://pdst.fm/e/traffic.megaphone.fm/WSJ1289536708.mp3
JSON
/v1/public/podcasts/the-journal-547598/episodes/weight-loss-drugs-are-gobbling-up-small-town-budgets
Markdown
/podcast/the-journal-547598/weight-loss-drugs-are-gobbling-up-small-town-budgets.md

Actions

  • POST https://stenobird.com/v1/public/podcasts/the-journal-547598/episodes/weight-loss-drugs-are-gobbling-up-small-town-budgets/transcription-requests
    Idempotently request low-priority transcript generation for this episode.
  • GET https://stenobird.com/podcast/the-journal-547598/weight-loss-drugs-are-gobbling-up-small-town-budgets.md
    Read the agent-friendly Markdown representation of this episode resource.

Summary

Many small towns across the country added GLP-1 weight-loss drugs to their employee health insurance plans. Now, some of those towns are being hit with huge unexpected premiums as use of the drugs continues to grow. Imani Moise speaks to a selectwoman from Belchertown, MA who helped navigate her town through a devastating bill and WSJ’s Owen Tucker-Smith takes us through the economics for towns around the country. Further Listening: - Trillion Dollar Shot - Novo Nordisk's CEO Has a Comeback Plan - Ozempic Is a Hit. So Why Is the Drugmaker’s CEO Out? Sign up for WSJ’s free What’s News newsletter. Learn more about your ad choices. Visit megaphone.fm/adchoices